Evidence map›Paper›PMID 30932350›Full record

ArticleThoracic cancer2019

Alteration in gene expression profiles of thymoma: Genetic differences and potential novel targets.

Fan-Jie Meng, Shuo Wang, Jun Zhang, Yi-Jie Yan, Chun-Yang Wang, Chun-Rui Yang, Zhi-Yu Guan, Chang-Li Wang

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Identification and Characterization of Non-Coding RNAs in Thymoma.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  8. Article
  9. Pathology of thymoma-where are we today?Journal of thoracic disease · 2020
    Review
  10. Combination of pembrolizumab andOncology letters · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Fan-Jie MengDepartment of Thoracic Surgery, The Second Hospital of Tianjin Medical University, Tianjin, China.ORCID 0000-0002-0783-1961
Shuo WangKey Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Jun ZhangDepartment of Thoracic Surgery, The Second Hospital of Tianjin Medical University, Tianjin, China.
Yi-Jie YanDepartment of Thoracic Surgery, The Second Hospital of Tianjin Medical University, Tianjin, China.
Chun-Yang WangDepartment of Neurology, Tianjin Medical University General Hospital, Tianjin, China.
Chun-Rui YangDepartment of Pathology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Zhi-Yu GuanDepartment of Thoracic Surgery, The Second Hospital of Tianjin Medical University, Tianjin, China.ORCID 0000-0003-1274-1706
Chang-Li WangKey Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Second Hospital of Tianjin Medical University · CNTianjin Medical University General Hospital · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study was conducted to investigate the gene expression profiles associated with thymoma to better understand the molecular mechanism underlying the pathogenesis of thymoma.

methodsEight patients with thymomas (type A, AB, B1, and B2) and four controls with thymic cysts were analyzed using microarray profiling to identify changes in gene expression.

resultsAcross all of our samples, 2319 messenger RNAs were upregulated and 2776 were downregulated in thymomas relative to thymic cysts. Gene ontology and pathway analyses revealed that a large number of genes participate in cellular functions, among which MHC class II protein complex assembly, assembly with peptide antigen, calcium activated phosphatidylcholine scrambling, and release of cytoplasmic sequestered NF-κB were dysregulated, whereas intestinal immune network for immunoglobulin A production, cytokine-cytokine receptor interaction, the calcium signaling pathway, and pathways related to autoimmune diseases were downregulated.

conclusionsOur results revealed gene expression differences between thymomas and thymic cysts, and identified key candidate genes/pathways that might be used as diagnostic markers and potential therapeutic targets to treat cancer metastasis.

Indexed as

Gene Expression Regulation, NeoplasticTranscriptomeBiomarkers, TumorCase-Control StudiesComputational BiologyFemaleGene Expression ProfilingGene OntologyHumansMaleMediastinal CystThymomaBiomarkers, TumorGene ontologymessenger RNAmicroarraypathway analysisthymoma

Identifiers

PMID30932350
PMCPMC6500959
OpenAlexW2927923246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.